HIV-1 Tat protein induces TNF-α and IL-10 production by human macrophages: Differential implication of PKC-βII and -δ isozymes and MAP kinases ERK1/2 and p38

Cellular Immunology

Volumn 254, Issue 1, 2008, Pages 46-55

  Leghmari, Kaoutar ^a   Contreras, Xavier ^a   Moureau, Corinne ^a   Bahraoui, Elmostafa ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

ERK1 2 MAP kinase; HIV 1; IL 10; Macrophages; NF B; p38 MAP kinase; PKC II; PKC ; Tat; TNF

Indexed keywords

INTERLEUKIN 10; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; PROTEIN KINASE C DELTA; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN 1 45; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; PRIORITY JOURNAL;

BLOTTING, WESTERN; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; ISOENZYMES; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 55049137934     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.06.011     Document Type: Article

References (59)

1. Cassol E., Alfano M., Biswas P., and Poli G. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J. Leukoc. Biol. 80 (2006) 1018-1030
2. Gill V., Shattock R.J., Freeman A.R., Robinson G., Griffin G.E., Gordon-Smith E.C., et al. Macrophages are the major target cell for HIV infection in long-term marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1. Br. J. Haematol. 93 (1996) 30-37
3. Meltzer M.S., Nakamura M., Hansen B.D., Turpin J.A., Kalter D.C., and Gendelman H.E. Macrophages as susceptible targets for HIV infection persistent viral reservoirs in tissue and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Hum. Retroviruses 6 (1990) 967-971
4. Collman R., Hassan N.F., Walker R., Godfrey B., Cutilli J., Hastings J.C., et al. J. Exp. Med. 170 (1989) 1149-1163
5. Kedzierska K., and Crowe S.M. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9 (2002) 1893-1903
6. Rich E.A., Orenstein J.M., and Jeang K.T. A macrophage-tropic HIV-1 that expresses green fluorescent protein and infects alveolar and blood monocyte-derived macrophages. J. Biomed. Sci. 9 (2002) 721-726
7. Etemad-Moghadam B., Rhone D., Steenbeke T., Sun Y., Manola J., Gelman R., et al. Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus. Vaccine 20 (2002) 1934-1937
8. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 98 (2001) 658-663
9. Arendt C.W., and Littman D.R. HIV: master of the host cell. Genome Biol. 2 (2001) REVIEWS1030
10. Cicala C., Arthos J., Selig S.M., Dennis Jr. G., Hosack D.A., Van Ryk D., et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99 (2002) 9380-9385
11. de la Fuente C., Santiago F., Deng L., Eadie C., Zilberman I., Kehn K., et al. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem. 3 (2002) 14
12. Simmons A., Aluvihare V., and McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14 (2001) 763-777
13. Clerici M., Wynn T.A., Berzofsky J.A., Blatt S.P., Hendrix C.W., Sher A., et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93 (1994) 768-775
14. Stylianou E., Aukrust P., Kvale D., Muller F., and Frol S.S. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy. Clin. Exp. Immunol. 116 (1999) 115-120
15. Wright S.C., Jewett A., Mitsuyasu R., and Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141 (1988) 99-104
16. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
17. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11 (1993) 165-190
18. Wang Y., and Rice A.P. Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 352 (2006) 485-492
19. Howard M., and O'Garra A. Biological properties of interleukin 10. Immunol. Today 13 (1992) 198-200
20. Rosenberg Z.F., and Fauci A.S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11 (1990) 176-180
21. Duh E.J., Maury W.J., Folks T.M., Fauci A.S., and Rabson A.B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86 (1989) 5974-5978
22. Folks T.M., Clouse K.A., Justement J., Rabson A., Duh E., Kehrl J.H., et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86 (1989) 2365-2368
23. Griffin G.E., Leung K., Folks T.M., Kunkel S., and Nabel G.J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339 (1989) 70-73
24. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86 (1989) 2336-2340
25. Badou A., Bennasser Y., Moreau M., Leclerc C., Benkirane M., and Bahraoui E. Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J. Virol. 74 (2000) 10551-10562
26. Bennasser Y., Badou A., Tkaczuk J., and Bahraoui E. Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. Virology 303 (2002) 174-180
27. Bennasser Y., and Bahraoui E. HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta. FASEB J. 16 (2002) 546-554
28. Wu Y., and Marsh J.W. Gene transcription in HIV infection. Microbes Infect. 5 (2003) 1023-1027
29. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., and Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. Aids 11 (1997) 1421-1431
30. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., and Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345 (1990) 84-86
31. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
32. Banki K., Hutter E., Gonchoroff N.J., and Perl A. Molecular ordering in HIV-induced apoptosis. Oxidative stress activation of caspases and cell survival are regulated by transaldolase. J. Biol. Chem. 273 (1998) 11944-11953
33. Huang L., Bosch I., Hofmann W., Sodroski J., and Pardee A.B. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T- lymphotropic HIV-1 strains. J. Virol. 72 (1998) 8952-8960
34. Contreras X., Bennasser Y., Chazal N., Moreau M., Leclerc C., Tkaczuk J., et al. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Virology 332 (2005) 316-328
35. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65 (1991) 961-967
36. Vives E., Charneau P., van Rietschoten J., Rochat H., and Bahraoui E. Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation using chemically synthesized Tat protein and Tat peptides. J. Virol. 68 (1994) 3343-3353
37. Lin W.W., and Chen B.C. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages. Br. J. Pharmacol. 121 (1997) 1749-1757
38. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
39. Birbach A., Gold P., Binder B.R., Hofer E., de Martin R., and Schmid J.A. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 277 (2002) 10842-10851
40. Fanales-Belasio E., Cafaro A., Cara A., Negri D.R., Fiorelli V., Butto S., et al. HIV-1 Tat-based vaccines: from basic science to clinical trials. DNA Cell Biol. 21 (2002) 599-610
41. Mayne M., Holden C.P., Nath A., and Geiger J.D. Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J. Immunol. 164 (2000) 6538-6542
42. Nath A., Conant K., Chen P., Scott C., and Major E.O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes A hit and run phenomenon. J. Biol. Chem. 274 (1999) 17098-17102
43. Westendorp M.O., Shatrov V.A., Schulze-Osthoff K., Frank R., Kraft M., Los M., et al. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14 (1995) 546-554
44. Gee K., Angel J.B., Mishra S., Blahoianu M.A., and Kumar A. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J. Immunol. 178 (2007) 798-807
45. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15 (1995) 2359-2366
46. Mellors J.W., Griffith B.P., Ortiz M.A., Landry M.L., and Ryan J.L. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163 (1991) 78-82
47. Akridge R.E., Oyafuso L.K., and Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153 (1994) 5782-5789
48. Saville M.W., Taga K., Foli A., Broder S., Tosato G., and Yarchoan R. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood 83 (1994) 3591-3599
49. Angel J.B., Saget B.M., Wang M.Z., Wang A., Dinarello C.A., and Skolnik P.R. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. J. Interferon Cytokine Res. 15 (1995) 575-584
50. Rabbi M.F., Finnegan A., Al-Harthi L., Song S., and Roebuck K.A. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 (1998) 321-331
51. Weissman D., Poli G., and Fauci A.S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res. Hum. Retroviruses 10 (1994) 1199-1206
52. Weissman D., Poli G., and Fauci A.S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 (1995) 442-449
53. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
54. Monick M.M., Carter A.B., Gudmundsson G., Geist L.J., and Hunninghake G.W. Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes. Am. J. Physiol. 275 (1998) L389-L397
55. Borgatti P., Zauli G., Cantley L.C., and Capitani S. Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha and -epsilon and -zeta isoforms in PC12 cells. Biochem. Biophys. Res. Commun. 242 (1998) 332-337
56. Ron D., and Kazanietz M.G. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 13 (1999) 1658-1676
57. Rahman A., Anwar K.N., Uddin S., Xu N., Ye R.D., Platanias L.C., et al. Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol. Cell. Biol. 21 (2001) 5554-5565
58. Lin M.Q., and Chang Z.L. Immunomodulated Signaling in Macrophages:Regulation of the MAPK Signaling Pathways by PKA and PKC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 31 (1999) 701-706
59. Li J.C., and Lau A.S. A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat. Immunology 121 (2007) 337-348